Liporush XT
Withdrawn from the US market on 2 April 2024 (according to the DSLD)
NDS Nutrition, food supplement from the US market
Label withdrawn from the US market. Liporush XT (NDS Nutrition), a food supplement au code-barres 811020910725, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- NDS Nutrition
- Barcode
- 811020910725
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Bovine Gelatin, Magnesium Stearate, Rice Flour, Silica, FD&C Blue 1, FD&C Red 40, FD&C Yellow 5, FD&C Yellow 6, Titanium Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Lipo|Burn Blend | Blend | 440 mg |
| Caffeine Anhydrous | Other substance | 320 mg |
| TeaCrine | Other substance | not stated |
| Cayenne, Powder (Capsicum annuum) | Plant | not stated |
| Amla Fruit Extract (Phyllanthus emblica) | Plant | not stated |
| Theobromine | Other substance | not stated |
| QU995 Quercetin | Other substance | not stated |
| Yohimbe Bark Extract (Pausinystalia johimbe) | Plant | not stated |
| Water|Shred Blend | Blend | 175 mg |
| Dandelion Root Extract | Plant | not stated |
| L-Carnitine | Other substance | not stated |
| Blackberry Extract (Rubus fruticosus) | Plant | not stated |
| Uva Ursi, Powder (Arctostaphylos uva-ursi) | Plant | not stated |
| Commiphora mukul Gugulipid extract (Commiphora mukul) | Plant | not stated |
| Neuro Recharge Blend | Blend | 55 mg |
| Rhodiola rosea Root Extract | Plant | not stated |
| KSM-66 (Withania somnifera) | Plant | not stated |
| Licorice | Plant | not stated |
| Holy Basil | Plant | not stated |
| Schisandra (Schisandra chinensis) | Plant | not stated |
| Kelp | Plant | not stated |
| Magnolia officinalis | Plant | not stated |
| Huperzine A | Other substance | 100 µg |
| Amino Fit Blend | Blend | 50 mg |
| Glutamine | Amino acid | not stated |
| Leucine | Amino acid | not stated |
| Isoleucine | Amino acid | not stated |
| Valine | Amino acid | not stated |
| Delivery Agent (Piper nigrum) | Plant | 2 mg |
| BioPerine (Piper nigrum) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Slim-Tox
Entered into DSLD on 25 March 2025. Withdrawn from the US market on 2 April 2024 (according to the DSLD).- Active ingredient added : 5-Hydroxytryptophan (quantity not stated)
- Active ingredient added : Acetyl-L-Carnitine (quantity not stated)
- Active ingredient added : Adrenal-Thyroid Support Blend (261 mg)
- Active ingredient added : Apple Cider Vinegar (quantity not stated)
- Active ingredient added : Ashwagandha Root Extract (quantity not stated)
- Active ingredient added : Bromelain (quantity not stated)
- Active ingredient added : Chamomile, Powder (quantity not stated)
- Active ingredient added : Conjugated Linoleic Acid (quantity not stated)
- Active ingredient added : Crave Control Agent (500 mg)
- Active ingredient added : Garcinia cambogia (quantity not stated)
- Active ingredient added : Grapefruit Seed Concentrate (quantity not stated)
- Active ingredient added : Gugulipid Gum Resin Extract (quantity not stated)
- Active ingredient added : Holy Basil Leaf Concentrate (quantity not stated)
- Active ingredient added : Iodine (300 mcg)
- Active ingredient added : Kelp Extract (quantity not stated)
- Active ingredient added : Lactobacillus acidophilus (quantity not stated)
- Active ingredient added : L-Carnitine L-Tartrate (quantity not stated)
- Active ingredient added : Licorice Root Extract (quantity not stated)
- Active ingredient added : Lipase (quantity not stated)
- Active ingredient added : L-Theanine (quantity not stated)
- Active ingredient added : Melatonin (quantity not stated)
- Active ingredient added : Papaya Enzyme (quantity not stated)
- Active ingredient added : Passionflower, Powder (quantity not stated)
- Active ingredient added : Peppermint Leaf Oil, Powder (quantity not stated)
- Active ingredient added : Probiotic-Digestive Blend (427 mg)
- Active ingredient added : Psyllium seed husk powder (quantity not stated)
- Active ingredient added : Safflower Oil (quantity not stated)
- Active ingredient added : Senna, Powder (quantity not stated)
- Active ingredient added : Sleep Blend (quantity not stated)
- Active ingredient added : Sleep-Tight Blend (514 mg)
- Active ingredient added : Tight Blend (quantity not stated)
- Active ingredient added : Valerian, Powder (quantity not stated)
- Active ingredient removed : Amino Fit Blend (50 mg)
- Active ingredient removed : Amla Fruit Extract (quantity not stated)
- Active ingredient removed : BioPerine (quantity not stated)
- Active ingredient removed : Blackberry Extract (quantity not stated)
- Active ingredient removed : Caffeine Anhydrous (320 mg)
- Active ingredient removed : Cayenne, Powder (quantity not stated)
- Active ingredient removed : Commiphora mukul Gugulipid extract (quantity not stated)
- Active ingredient removed : Dandelion Root Extract (quantity not stated)
- Active ingredient removed : Delivery Agent (2 mg)
- Active ingredient removed : Glutamine (quantity not stated)
- Active ingredient removed : Holy Basil (quantity not stated)
- Active ingredient removed : Huperzine A (100 mcg)
- Active ingredient removed : Isoleucine (quantity not stated)
- Active ingredient removed : Kelp (quantity not stated)
- Active ingredient removed : KSM-66 (quantity not stated)
- Active ingredient removed : L-Carnitine (quantity not stated)
- Active ingredient removed : Leucine (quantity not stated)
- Active ingredient removed : Licorice (quantity not stated)
- Active ingredient removed : Lipo|Burn Blend (440 mg)
- Active ingredient removed : Magnolia officinalis (quantity not stated)
- Active ingredient removed : Neuro Recharge Blend (55 mg)
- Active ingredient removed : QU995 Quercetin (quantity not stated)
- Active ingredient removed : Rhodiola rosea Root Extract (quantity not stated)
- Active ingredient removed : Schisandra (quantity not stated)
- Active ingredient removed : TeaCrine (quantity not stated)
- Active ingredient removed : Theobromine (quantity not stated)
- Active ingredient removed : Uva Ursi, Powder (quantity not stated)
- Active ingredient removed : Valine (quantity not stated)
- Active ingredient removed : Water|Shred Blend (175 mg)
- Active ingredient removed : Yohimbe Bark Extract (quantity not stated)
Official label: Censor
Entered into DSLD on 25 March 2025. Withdrawn from the US market on 2 April 2024 (according to the DSLD).- Active ingredient added : Borage Oil (quantity not stated)
- Active ingredient added : Calories (20 Calorie(s))
- Active ingredient added : Cholesterol (5 mg)
- Active ingredient added : CLA/Omega 3-6-9 Blend (2,000 mg)
- Active ingredient added : Docosahexaenoic Acid (quantity not stated)
- Active ingredient added : Eicosapentaenoic Acid (quantity not stated)
- Active ingredient added : Evening Primrose Oil (quantity not stated)
- Active ingredient added : Fish Oil (quantity not stated)
- Active ingredient added : Flaxseed Oil (quantity not stated)
- Active ingredient added : Krill Oil (quantity not stated)
- Active ingredient added : Monounsaturated Fat (0 Gram(s))
- Active ingredient added : Omega-Krill Blend (quantity not stated)
- Active ingredient added : Polyunsaturated Fat (1.5 Gram(s))
- Active ingredient added : Protein (< 1 mg)
- Active ingredient added : Safflower Oil (quantity not stated)
- Active ingredient added : Saturated Fat (0 Gram(s))
- Active ingredient added : Total Fat (2 Gram(s))
- Active ingredient added : Vitamin E (6.7 mg)
- Active ingredient removed : Amino Fit Blend (50 mg)
- Active ingredient removed : Amla Fruit Extract (quantity not stated)
- Active ingredient removed : BioPerine (quantity not stated)
- Active ingredient removed : Blackberry Extract (quantity not stated)
- Active ingredient removed : Caffeine Anhydrous (320 mg)
- Active ingredient removed : Cayenne, Powder (quantity not stated)
- Active ingredient removed : Commiphora mukul Gugulipid extract (quantity not stated)
- Active ingredient removed : Dandelion Root Extract (quantity not stated)
- Active ingredient removed : Delivery Agent (2 mg)
- Active ingredient removed : Glutamine (quantity not stated)
- Active ingredient removed : Holy Basil (quantity not stated)
- Active ingredient removed : Huperzine A (100 mcg)
- Active ingredient removed : Isoleucine (quantity not stated)
- Active ingredient removed : Kelp (quantity not stated)
- Active ingredient removed : KSM-66 (quantity not stated)
- Active ingredient removed : L-Carnitine (quantity not stated)
- Active ingredient removed : Leucine (quantity not stated)
- Active ingredient removed : Licorice (quantity not stated)
- Active ingredient removed : Lipo|Burn Blend (440 mg)
- Active ingredient removed : Magnolia officinalis (quantity not stated)
- Active ingredient removed : Neuro Recharge Blend (55 mg)
- Active ingredient removed : QU995 Quercetin (quantity not stated)
- Active ingredient removed : Rhodiola rosea Root Extract (quantity not stated)
- Active ingredient removed : Schisandra (quantity not stated)
- Active ingredient removed : TeaCrine (quantity not stated)
- Active ingredient removed : Theobromine (quantity not stated)
- Active ingredient removed : Uva Ursi, Powder (quantity not stated)
- Active ingredient removed : Valine (quantity not stated)
- Active ingredient removed : Water|Shred Blend (175 mg)
- Active ingredient removed : Yohimbe Bark Extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cayenne, Powder
Read the warning, when it applies and the studies cited
CAYENNE - CAPSICUM ANNUUM Oral
Cautions and warnings
Condition of application: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
Sources cited by Health Canada (2)
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condition of application: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Cautions and warnings
Condition of application: All products.
For external use only (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Known adverse reactions
Condition of application: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
Sources cited by Health Canada (5)
- APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
- Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
- McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
- Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review
- Amla Fruit Extract
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- L-Carnitine
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
- Uva Ursi, Powder
Read the warning, when it applies and the studies cited
Bearberry - Arctostaphylos Uva-Ursi
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Applies to products providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).
Sources cited by Health Canada (2)
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).
Sources cited by Health Canada (8)
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
- Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.
- KSM-66
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
- Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : NDS Nutrition
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Liporush XT : étiquette retirée du marché américain (NDS Nutrition): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/811020910725-liporush-xt-nds-nutrition, updated 21 May 2025.